Leon Vorobeichik1, Yasmine Hoydonckx1,2, Pranab Kumar1,2, Arlene Buzon-Tan2, Susan Walker2, Kyle Kirkham1,2, Dharini Ilangomaran2, Lashmi Venkatraghavan1,2, Atul J Prabhu1,2, Anuj Bhatia3,4,5. 1. Department of Anesthesia and Pain Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. 2. Department of Anesthesia and Pain Management, Toronto Western Hospital - University Health Network, Toronto, ON, Canada. 3. Department of Anesthesia and Pain Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. anuj.bhatia@uhn.ca. 4. Department of Anesthesia and Pain Management, Toronto Western Hospital - University Health Network, Toronto, ON, Canada. anuj.bhatia@uhn.ca. 5. Toronto Western Hospital, McL 2-405, Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada. anuj.bhatia@uhn.ca.
Abstract
PURPOSE: Patient-controlled oral analgesia (PCOA) is a novel method of oral opioid administration using set doses of short-acting oral opioids self-administered by patients with a "lockout" period as part of a multimodal regimen. Failure of PCOA can result in severe postoperative pain necessitating use of intravenous patient-controlled analgesia (IV-PCA) with its potential complications. This study evaluated factors related to success or failure of PCOA following total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: We conducted a retrospective cohort study of all adults who underwent THA and TKA at our institution by extracting data from the proprietary database of our acute pain service. Patient, anesthetic, and surgical variables associated with PCOA failure defined as inadequate analgesia requiring conversion to IV-PCA within 24 hr following THA and TKA were evaluated. Univariable and multivariable logistic regression analyses were performed to identify predictors of PCOA failure. RESULTS: Of the 926 patients who underwent THA or TKA (n = 411 and 515, respectively), 147 (15.9%) patients (67 THA and 80 TKA patients) had PCOA failure with moderate-to-severe pain. Multivariable regression analysis showed that PCOA failure occurred in those with younger age (adjusted odds ratio [aOR] per year of age, 0.97; 99% CI, 0.95 to 0.99; P < 0.001), preoperative chronic use of controlled-release opioids (aOR, 3.45; 99% CI, 1.60 to 7.35; P < 0.001), and with the use of general anesthesia vs spinal anesthesia (aOR, 2.86; 99% CI, 1.20 to 6.84; P = 0.002). CONCLUSION: The use of PCOA provides adequate analgesia to a majority of patients undergoing THA and TKA. Factors predictive for PCOA failure should be considered when choosing the primary breakthrough analgesic modality following THA/TKA.
PURPOSE: Patient-controlled oral analgesia (PCOA) is a novel method of oral opioid administration using set doses of short-acting oral opioids self-administered by patients with a "lockout" period as part of a multimodal regimen. Failure of PCOA can result in severe postoperative pain necessitating use of intravenous patient-controlled analgesia (IV-PCA) with its potential complications. This study evaluated factors related to success or failure of PCOA following total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: We conducted a retrospective cohort study of all adults who underwent THA and TKA at our institution by extracting data from the proprietary database of our acute pain service. Patient, anesthetic, and surgical variables associated with PCOA failure defined as inadequate analgesia requiring conversion to IV-PCA within 24 hr following THA and TKA were evaluated. Univariable and multivariable logistic regression analyses were performed to identify predictors of PCOA failure. RESULTS: Of the 926 patients who underwent THA or TKA (n = 411 and 515, respectively), 147 (15.9%) patients (67 THA and 80 TKA patients) had PCOA failure with moderate-to-severe pain. Multivariable regression analysis showed that PCOA failure occurred in those with younger age (adjusted odds ratio [aOR] per year of age, 0.97; 99% CI, 0.95 to 0.99; P < 0.001), preoperative chronic use of controlled-release opioids (aOR, 3.45; 99% CI, 1.60 to 7.35; P < 0.001), and with the use of general anesthesia vs spinal anesthesia (aOR, 2.86; 99% CI, 1.20 to 6.84; P = 0.002). CONCLUSION: The use of PCOA provides adequate analgesia to a majority of patients undergoing THA and TKA. Factors predictive for PCOA failure should be considered when choosing the primary breakthrough analgesic modality following THA/TKA.
Entities:
Keywords:
PCOA; hip and knee arthroplasty; patient-controlled oral analgesia
Authors: Pia A E Puolakka; Michael G F Rorarius; Miika Roviola; Timo J S Puolakka; Klaus Nordhausen; Leena Lindgren Journal: Eur J Anaesthesiol Date: 2010-05 Impact factor: 4.330
Authors: Alejandro Lizaur-Utrilla; Daniel Martinez-Mendez; Francisco A Miralles-Muñoz; Luis Marco-Gomez; Fernando A Lopez-Prats Journal: J Arthroplasty Date: 2017-03-16 Impact factor: 4.757
Authors: Spencer S Liu; Asokumar Buvanendran; James P Rathmell; Mona Sawhney; James J Bae; Mario Moric; Stephen Perros; Ashley J Pope; Lazaros Poultsides; Craig J Della Valle; Naomi S Shin; Colin J L McCartney; Yan Ma; Mahendrakumar Shah; Monica J Wood; Smith C Manion; Thomas P Sculco Journal: Int Orthop Date: 2012-07-29 Impact factor: 3.075
Authors: M Choinière; B E Rittenhouse; S Perreault; D Chartrand; P Rousseau; B Smith; C Pepler Journal: Anesthesiology Date: 1998-12 Impact factor: 7.892